-
Eye On the Cure Research News
First Patient Receives ProQR’s Emerging USH2A Therapy in Clinical Trial
-
Eye On the Cure Research News
First Human Study in US for Induced Pluripotent Stem Cells to be Launched for Advanced Dry AMD
Our Track Record
The Foundation drives the research of prevention, treatments, and cures for people affected by retinal degenerative diseases.
-
1st gene therapy
for any inherited disease to be approved by the FDA
learn more -
$760M dollars raised
since 1971
learn more -
35 VisionWalk events
throughout the United States
learn more -
75 grants awarded
in 2019 – over 90 investigators, 67 institutions
Learn more
The Foundation in the News
First Human Study in US for Induced Pluripotent Stem Cells to be Launched for Advanced Dry AMD
-
Dec 17, 2019 Beacon Stories
Ashlyn Experiences Joy in Day-To-Day Life After Sight Is Restored
-
Dec 16, 2019 Eye On the Cure Research News
First Patient Receives ProQR’s AON Therapy in Clinical Trial for RP Caused by RHO-P23H Mutation
-
Dec 11, 2019 Eye On the Cure Research News
Families and Scientists Meet to Discuss Therapy Development for People with RDH12 Mutations
Living with vision loss can be difficult, but you don't have to do it alone
View local chaptersGet Involved
-
Take important steps toward a cure by participating in a 5k VisionWalk
Join a Walk -
Join people coming together to find a cure from all over the country
Search Our Events -
Make a difference today and support promising research by donating a one-time gift
Donate Now
Welcome to the new Foundation site — supported in partnership with Genentech, A Member of the Roche Group